- CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) is executing a 10-for-1 reverse stock split on September 4, 2026.
- This strategic move aims to increase the share price to comply with Nasdaq’s minimum price listing rules.
- The reverse split will not alter the total value of investor holdings, though it will reduce the number of outstanding shares.
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) is a leading biotechnology company. The company’s stock currently trades at $3.25 per share, with a total company value, or market capitalization, of approximately $42.14 million. The stock performance has experienced a wide trading range over the past year, from a low of $2.64 to a high of $31.80.
On September 4, 2026, CollPlant Biotechnologies implements a 10-for-1 reverse stock split. This action, also known as share consolidation, combines every ten existing shares into one new share. A reverse stock split increases the price per share but does not change the total value of an investor’s holdings. The stock will continue to trade under the symbol CLGN.
The company is performing this reverse split as part of a plan to meet Nasdaq’s listing rules. Nasdaq requires a company’s stock to maintain a minimum price requirement to remain on the exchange. This strategic move is designed to increase the company’s share price and ensure it stays in compliance with this requirement.
The decision was approved by shareholders at a meeting on August 18, 2026. As highlighted by PR Newswire, every ten outstanding shares will be converted into one share. The company will not issue parts of a share, known as fractional shares, as part of this process.
